State of New Jersey Common Pension Fund D Cuts Stock Holdings in Dorman Products, Inc. $DORM

Dorman Products (NASDAQ:DORM) reported Q3 EPS of $2.62, significantly exceeding analyst estimates of $2.31, though revenue of $543.74 million slightly missed expectations, while the company issued optimistic FY25 EPS guidance of $8.60-$8.90. Institutional investor activity was mixed, with State of New Jersey Common Pension Fund D reducing its stake by 5.1%, but other major funds increasing positions, contributing to high overall institutional ownership. Analysts maintain a generally positive outlook, with a consensus "Buy" rating and an average price target of $175.00, despite a recent insider sale by the CAO.

Analysis

Dorman Products (NASDAQ:DORM) reported Q3 EPS of $2.62, significantly beating analyst consensus of $2.31. While revenue of $543.74 million grew 7.9% year-over-year, it marginally missed the $548.60 million expectation. The company's optimistic FY 2025 EPS guidance of $8.60-$8.90 suggests strong confidence in future profitability.

Analyst sentiment remains largely positive, with a consensus "Buy" rating and an average price target of $175.00, supported by multiple "Buy," "Overweight," and "Outperform" ratings. Institutional ownership is substantial at 84.70%, though activity was mixed, with some funds reducing stakes while others increased or initiated positions.

The stock trades at a P/E ratio of 16.70 and a beta of 0.84, indicating relative value and lower volatility. DORM's stock opened at $134.13, below its 50-day moving average of $153.09, suggesting short-term technical weakness. However, strong liquidity metrics (quick ratio 1.21, current ratio 2.94) and a low debt-to-equity ratio of 0.28 highlight a healthy balance sheet.

A notable insider transaction involved CAO Gregory C. Bowen selling 1,453 shares, reducing his position by 23.77%. This insider sale, while a potential signal, should be weighed against the high institutional ownership and overall positive analyst outlook.

Key Decisions for Investors

• Investors should consider DORM's strong Q3 EPS beat and optimistic FY25 guidance as key drivers for potential upside, aligning with the consensus "Buy" rating and $175.00 price target.
• Monitor the stock's technical performance, specifically its trading below the 50-day moving average, which could indicate a short-term buying opportunity if fundamental strength persists.
• Assess the significance of the CAO's recent share sale against the backdrop of high institutional ownership and the company's healthy financial ratios.